MARCKS and cancer: Considering that majority of cancer-related studies have described an oncogenic role of MARCKS to be associated with its phosphorylated form, inhibiting the molecular factors that directly or indirectly induce the phosphorylation and activation of MARCKS is a possible therapeutic strategy in improving disease response.